Effects of Reducing the Upper Limit of Normal TSH Values [7]

JAMA

Volumn 290, Issue 24, 2003, Pages 3195-3196

  Fatourechi, Vahab ^a   Klee, George G ^a   Grebe, Stefan K ^a   Bahn, Rebecca S ^a   Brennan, Michael D ^a   Hay, Ian D ^a   McIver, Bryan ^a   Morris III, John C ^a  

^a Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THYROTROPIN; THYROXINE;

ADULT; AGE; AGED; FEMALE; HORMONE SUBSTITUTION; HUMAN; HYPOTHYROIDISM; INTERNATIONAL CLASSIFICATION OF DISEASES; LETTER; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; NORMAL VALUE; PRIORITY JOURNAL; SEX DIFFERENCE; THYROID FUNCTION; THYROTROPIN BLOOD LEVEL;

EID: 0345802948     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.290.24.3195-a     Document Type: Letter

References (5)

1. Baloch Z, Carayon P, Conte-Devolx B, et al, Guidelines Committee, National Academy of Clinical Biochemistry. Laboratory medicine practice guidelines: laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid, 2003;13:3-126.
2. Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002;87:489-499.
3. Vanderpump MP, Tunbridge WM, French JM, et al. The incidence of thyroid disorders in the community: a twenty-year follow up of the Whickham Survey. Clin Endocrinol (Oxf). 1995;43:55-68.
4. AACE Thyroid task Force, American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism. Endocr Pract. 2002;8:457-467.
5. Fatourechi V. Adverse effects of subclinical hyperthyroidism. Lancet. 2001;358:856-857.